A META-ANALYSIS OF PROGNOSTIC FACTORS IN ADVANCED OVARIAN-CANCER WITH MEDIAN SURVIVAL AND OVERALL SURVIVAL (MEASURED WITH THE LOG (RELATIVE RISK)) AS MAIN OBJECTIVES

被引:93
作者
VOEST, EE
VANHOUWELINGEN, JC
NEIJT, JP
机构
[1] UTRECHT UNIV HOSP,DEPT ONCOL,CATHARIJNESINGEL 101,3511 GV UTRECHT,NETHERLANDS
[2] STATE UNIV LEIDEN,DEPT MED STAT,2312 AV LEIDEN,NETHERLANDS
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 04期
关键词
D O I
10.1016/0277-5379(89)90208-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:711 / 720
页数:10
相关论文
共 60 条
[1]   A RANDOMIZED STUDY OF SINGLE AGENT VS COMBINATION CHEMOTHERAPY IN FIGO STAGE-IIB, STAGE-III AND STAGE-IV OVARIAN ADENOCARCINOMA [J].
AABO, K ;
HALD, I ;
HORBOV, S ;
DOMBERNOWSKY, P ;
HANSEN, HH ;
SORENSEN, HM ;
LUNDVALL, F ;
NIELSEN, NC ;
SORENSEN, BL .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (04) :475-481
[2]  
ABDULLA U, 1983, 13TH P INT C CHEM
[3]  
BARLOW JJ, 1980, CANCER, V46, P1333, DOI 10.1002/1097-0142(19800915)46:6<1333::AID-CNCR2820460606>3.0.CO
[4]  
2-3
[5]   ADVANCED OVARIAN-CANCER - A PROSPECTIVE RANDOMIZED TRIAL OF CHLORAMBUCIL VERSUS COMBINED CYCLOPHOSPHAMIDE AND CIS-DIAMMINEDICHLOROPLATINUM [J].
BELL, DR ;
WOODS, RL ;
LEVI, JA ;
FOX, RM ;
TATTERSALL, MHN .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (03) :245-249
[6]   CISPLATIN REGIMENS AND IMPROVED PROGNOSIS OF PATIENTS WITH POORLY DIFFERENTIATED OVARIAN-CANCER [J].
BRUCKNER, HW ;
COHEN, CJ ;
GOLDBERG, JD ;
KABAKOW, B ;
WALLACH, RC ;
DEPPE, G ;
REISMAN, AZ ;
GUSBERG, SB ;
HOLLAND, JF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (06) :653-658
[7]  
BRUCKNER HW, 1981, CANCER, V47, P2288, DOI 10.1002/1097-0142(19810501)47:9<2288::AID-CNCR2820470931>3.0.CO
[8]  
2-3
[9]  
BRUCKNER HW, 1986, COMMUNICATION
[10]  
CARMOPEREIRA J, 1981, CANCER, V48, P1947, DOI 10.1002/1097-0142(19811101)48:9<1947::AID-CNCR2820480906>3.0.CO